[{"Assets_0_Q2_USD":117415503.0,"CommonStockSharesOutstanding_0_Q2_shares":3545057.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-230733.0,"NetIncomeLoss_1_Q2_USD":182749.0,"NetIncomeLoss_2_Q2_USD":182299.0,"StockholdersEquity_0_Q2_USD":5000006.0,"Ticker":"IMVT","CIK":"1764013","name":"HEALTH SCIENCES ACQUISITIONS CORP","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]